First-line thalidomide-dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma

No authors listed

No authors listed. Bone Marrow Transplant. 2009 Jun.

. 2009 Jun;43(11):893.

doi: 10.1038/bmt.2009.113.

No abstract available

Retraction of

First-line thalidomide-dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma.
Abdelkefi A, Torjman L, Ben Romdhane N, Ladeb S, El Omri H, Ben Othman T, Elloumi M, Bellaj H, Lakhal A, Jeddi R, Aissaouï L, Saad A, Hsaïri M, Boukef K, Dellagi K, Ben Abdeladhim A. Abdelkefi A, et al. Bone Marrow Transplant. 2005 Aug;36(3):193-8. doi: 10.1038/sj.bmt.1705050. Bone Marrow Transplant. 2005. Retraction in: Bone Marrow Transplant. 2009 Jun;43(11):893. doi: 10.1038/bmt.2009.113. PMID: 15968290 Retracted. Clinical Trial.